Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Rtn2 Deficiency Results in an Autosomal Recessive Distal Motor Neuropathy With Lower Limb Spasticity Publisher Pubmed



Maroofian R1 ; Sarraf P2, 3 ; Obrien TJ4, 5 ; Kamel M6 ; Cakar A1, 7 ; Elkhateeb N8 ; Lau T1 ; Patil SJ9 ; Record CJ1 ; Horga A1 ; Essid M10 ; Selim L6 ; Benrhouma H10 ; Younes TB10 Show All Authors
Authors
  1. Maroofian R1
  2. Sarraf P2, 3
  3. Obrien TJ4, 5
  4. Kamel M6
  5. Cakar A1, 7
  6. Elkhateeb N8
  7. Lau T1
  8. Patil SJ9
  9. Record CJ1
  10. Horga A1
  11. Essid M10
  12. Selim L6
  13. Benrhouma H10
  14. Younes TB10
  15. Zifarelli G11
  16. Pagnamenta AT12
  17. Bauer P11
  18. Khundadze M13
  19. Mirecki A13
  20. Kamel SM14
  21. Elmonem MA15
  22. Karimiani EG16, 17
  23. Jamshidi Y16
  24. Offiah AC18
  25. Rossor AM1
  26. Youssefturki IB10
  27. Hubner CA13, 19
  28. Munot P20
  29. Reilly MM1
  30. Brown AEX4, 5
  31. Nagy S1, 21
  32. Houlden H1
Show Affiliations
Authors Affiliations
  1. 1. Centre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, WC1N 3BG, United Kingdom
  2. 2. Department of Neuromuscular Diseases, Iranian Centre of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, 1416753955, Iran
  3. 3. Department of Neurology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, 1416753955, Iran
  4. 4. Institute of Clinical Sciences, Imperial College London, London, SW7 2AZ, United Kingdom
  5. 5. MRC Laboratory of Medical Sciences, London, W12 0HS, United Kingdom
  6. 6. Department of Pediatrics, Neurology and Metabolic Division, Kasr Alainy Faculty of Medicine, Cairo University, Cairo, 4240310, Egypt
  7. 7. Neuromuscular Unit, Istanbul Faculty of Medicine, Istanbul University, Istanbul, 34093, Turkey
  8. 8. Department of Clinical Genetics, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, United Kingdom
  9. 9. Division of Medical Genetics, Mazumdar Shaw Medical Center, Narayana Hrudayalaya Hospital, Bangalore, 560099, India
  10. 10. LR18SP04, Department of Child and Adolescent Neurology, National Institute Mongi Ben Hmida of Neurology, University of Tunis El Manar, Tunis, 1007, Tunisia
  11. 11. CENTOGENE GmbH, Rostock, 18055, Germany
  12. 12. NIHR Oxford Biomedical Research Centre, Centre for Human Genetics, University of Oxford, Oxford, OX3 9DU, United Kingdom
  13. 13. Institute of Human Genetics, Jena University Hospital, Friedrich Schiller University, Jena, 07747, Germany
  14. 14. Department of Radiology, Cairo University, Cairo, 12613, Egypt
  15. 15. Department of Clinical and Chemical Pathology, Kasr Alainy Faculty of Medicine, Cairo University, Cairo, 12613, Egypt
  16. 16. Molecular and Clinical Sciences Institute, St. George's, University of London, London, SW17 0RE, United Kingdom
  17. 17. Innovative Medical Research Center, Mashhad Branch, Islamic Azad University, Mashhad, 9187147578, Iran
  18. 18. Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, S10 2RX, United Kingdom
  19. 19. Center for Rare Diseases, Jena University Hospital, Friedrich Schiller Universitat, Jena, 07747, Germany
  20. 20. Dubowitz Neuromuscular Centre, Great Ormond Street Hospital NHS Trust, London, WC1N 3JH, United Kingdom
  21. 21. Department of Neurology, University Hospital Basel, University of Basel, Basel, 4031, Switzerland

Source: Brain Published:2024


Abstract

Heterozygous RTN2 variants have been previously identified in a limited cohort of families affected by autosomal dominant spastic paraplegia (SPG12-OMIM:604805) with a variable age of onset. Nevertheless, the definitive validity of SPG12 remains to be confidently confirmed due to the scarcity of supporting evidence. In this study, we identified and validated seven novel or ultra-rare homozygous loss-of-function RTN2 variants in 14 individuals from seven consanguineous families with distal hereditary motor neuropathy (dHMN) using exome, genome and Sanger sequencing coupled with deep-phenotyping. All affected individuals (seven males and seven females, aged 9-50 years) exhibited weakness in the distal upper and lower limbs, lower limb spasticity and hyperreflexia, with onset in the first decade of life. Nerve conduction studies revealed axonal motor neuropathy with neurogenic changes in the electromyography. Despite a slowly progressive disease course, all patients remained ambulatory over a mean disease duration of 19.71 ± 13.70 years. Characterization of Caenorhabditis elegans RTN2 homologous loss-of-function variants demonstrated morphological and behavioural differences compared with the parental strain. Treatment of the mutant with an endoplasmic/sarcoplasmic reticulum Ca2+ reuptake inhibitor (2,5-di-tert-butylhydroquinone) rescued key phenotypic differences, suggesting a potential therapeutic benefit for RTN2-disorder. Despite RTN2 being an endoplasmic reticulum (ER)-resident membrane shaping protein, our analysis of patient fibroblast cells did not find significant alterations in ER structure or the response to ER stress. Our findings delineate a distinct form of autosomal recessive dHMN with pyramidal features associated with RTN2 deficiency. This phenotype shares similarities with SIGMAR1-related dHMN and Silver-like syndromes, providing valuable insights into the clinical spectrum and potential therapeutic strategies for RTN2-related dHMN. © 2024 The Author(s).